460 related articles for article (PubMed ID: 19525010)
1. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
2. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.
Brodie CR; Collins JG; Aldrich-Wright JR
Dalton Trans; 2004 Apr; (8):1145-52. PubMed ID: 15252653
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning.
Huang CP; Fang WH; Lin LI; Chiou RY; Kan LS; Chi NH; Chen YR; Lin TY; Lin SB
Toxicol Appl Pharmacol; 2008 Mar; 227(3):331-8. PubMed ID: 18164362
[TBL] [Abstract][Full Text] [Related]
5. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
[TBL] [Abstract][Full Text] [Related]
6. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
7. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
8. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
9. Platinum(II) complexes with dipyridophenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA.
Ma DL; Che CM; Yan SC
J Am Chem Soc; 2009 Feb; 131(5):1835-46. PubMed ID: 18998644
[TBL] [Abstract][Full Text] [Related]
10. The topopyrones poison human DNA topoisomerases I and II.
Khan QA; Elban MA; Hecht SM
J Am Chem Soc; 2008 Oct; 130(39):12888-9. PubMed ID: 18774813
[TBL] [Abstract][Full Text] [Related]
11. Organoplatinum(II) complexes with nucleobase motifs as inhibitors of human topoisomerase II catalytic activity.
Wang P; Leung CH; Ma DL; Lu W; Che CM
Chem Asian J; 2010 Oct; 5(10):2271-80. PubMed ID: 20730852
[TBL] [Abstract][Full Text] [Related]
12. Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy.
Becker K; Herold-Mende C; Park JJ; Lowe G; Schirmer RH
J Med Chem; 2001 Aug; 44(17):2784-92. PubMed ID: 11495589
[TBL] [Abstract][Full Text] [Related]
13. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
14. A bifunctional platinum(II) complex capable of intercalation and hydrogen-bonding interactions with DNA: binding studies and cytotoxicity.
Ma DL; Che CM
Chemistry; 2003 Dec; 9(24):6133-44. PubMed ID: 14679525
[TBL] [Abstract][Full Text] [Related]
15. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
[TBL] [Abstract][Full Text] [Related]
16. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
17. Remarkable anticancer activity of ferrocenyl-terpyridine platinum(ii) complexes in visible light with low dark toxicity.
Mitra K; Basu U; Khan I; Maity B; Kondaiah P; Chakravarty AR
Dalton Trans; 2014 Jan; 43(2):751-63. PubMed ID: 24149439
[TBL] [Abstract][Full Text] [Related]
18. Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.
Jensen LH; Thougaard AV; Grauslund M; Søkilde B; Carstensen EV; Dvinge HK; Scudiero DA; Jensen PB; Shoemaker RH; Sehested M
Cancer Res; 2005 Aug; 65(16):7470-7. PubMed ID: 16103101
[TBL] [Abstract][Full Text] [Related]
19. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
20. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
